Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Ecopetrol
EC
Taylor Morrison Home
TMHC
KB Home
KBH
US Stock MarketDetailed Quotes
AVDL Avadel Pharmaceuticals
- 8.010
- -0.110-1.35%
Close Mar 28 16:00 ET
- 8.020
- +0.010+0.12%
Post 17:12 ET
774.00MMarket Cap-15.71P/E (TTM)
8.305High7.890Low677.42KVolume8.190Open8.120Pre Close5.43MTurnover0.80%Turnover RatioLossP/E (Static)96.63MShares19.09052wk High10.48P/B679.33MFloat Cap7.39052wk Low--Dividend TTM84.81MShs Float43.600Historical High--Div YieldTTM5.11%Amplitude0.710Historical Low8.008Avg Price1Lot Size
Avadel Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 504.79%169.12M | 159.14%50.41M | 613.22%50.03M | 2,674.33%41.5M | 27.18M | 27.96M | 19.45M | 7.01M | 1.5M | 0 |
| Operating revenue | 504.79%169.12M | 159.14%50.41M | 613.22%50.03M | 2,674.33%41.5M | --27.18M | --27.96M | --19.45M | --7.01M | --1.5M | --0 |
| Cost of revenue | 1,705.79%15.28M | 594.37%4.81M | 5,160.68%6.16M | 7,644.44%2.79M | 1.52M | 846K | 693K | 117K | 36K | 0 |
| Gross profit | 467.32%153.84M | 143.06%45.6M | 536.07%43.87M | 2,551.78%38.72M | 25.66M | 27.12M | 18.76M | 6.9M | 1.46M | 0 |
| Operating expense | 18.96%196.24M | 11.99%48.9M | 5.21%44.2M | 0.89%51.46M | 82.67%51.69M | 73.25%164.97M | 88.06%43.66M | 146.68%42.01M | 93.59%51M | -1.15%28.3M |
| Selling and administrative expenses | 19.34%181.04M | 8.04%44.62M | 3.16%40.39M | 1.34%47.41M | 98.72%48.62M | 103.59%151.71M | 143.22%41.3M | 177.80%39.16M | 114.54%46.78M | 13.09%24.47M |
| Research and development costs | 14.59%15.2M | 81.18%4.27M | 33.49%3.8M | -4.07%4.05M | -19.90%3.07M | -35.94%13.26M | -62.17%2.36M | -2.86%2.85M | -7.00%4.22M | -45.22%3.83M |
| Operating profit | 69.24%-42.4M | 86.76%-3.3M | 99.07%-327K | 74.28%-12.74M | 8.00%-26.04M | -44.78%-137.85M | -7.25%-24.9M | -106.18%-35.11M | -88.05%-49.54M | 1.15%-28.3M |
| Net non-operating interest income expense | -9.55%-10.83M | -14.78%-2.7M | -42.57%-2.82M | -18.34%-2.72M | 20.47%-2.59M | 19.90%-9.89M | 27.68%-2.35M | 44.50%-1.98M | 34.54%-2.3M | -61.58%-3.26M |
| Non-operating interest expense | 9.55%10.83M | 14.78%2.7M | 42.57%2.82M | 18.34%2.72M | -20.47%2.59M | -19.90%9.89M | -27.68%2.35M | -44.50%1.98M | -34.54%2.3M | 61.58%3.26M |
| Other net income (expense) | 131.82%4.15M | 163.48%1.04M | -32.45%610K | 109.00%1.13M | 613.99%1.38M | -236.05%-13.04M | -82.55%-1.63M | 74.66%903K | -267.82%-12.51M | 285.58%193K |
| Gain on sale of security | 4,670.11%4.15M | 163.48%1.04M | -32.45%610K | 80.74%1.13M | 613.99%1.38M | 116.23%87K | -52.24%-1.63M | 101.56%903K | 224.48%623K | 285.58%193K |
| Special income (charges) | --0 | --0 | --0 | --0 | ---- | -292.50%-13.13M | --0 | --0 | -265.51%-13.13M | ---- |
| -Less：Restructuring and merger&acquisition | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | --13.13M | --0 | ---- | --13.13M | ---- |
| Income before tax | 69.47%-49.08M | 82.82%-4.96M | 92.99%-2.54M | 77.73%-14.33M | 13.12%-27.25M | -44.27%-160.78M | -5.56%-28.89M | -80.24%-36.19M | -93.50%-64.34M | -2.01%-31.36M |
| Income tax | 50.70%-247K | 180.00%80K | -1.12%88K | -665.56%-509K | 116.03%93K | -101.93%-501K | -217.65%-100K | 27.14%89K | -99.70%90K | 86.58%-580K |
| Net income | 69.53%-48.83M | 82.48%-5.04M | 92.76%-2.63M | 78.55%-13.82M | 11.18%-27.34M | -16.59%-160.28M | -4.87%-28.79M | -80.06%-36.27M | -1.56%-64.43M | -16.50%-30.78M |
| Net income continuous Operations | 69.53%-48.83M | 82.48%-5.04M | 92.76%-2.63M | 78.55%-13.82M | 11.18%-27.34M | -16.59%-160.28M | -4.87%-28.79M | -80.06%-36.27M | -1.56%-64.43M | -16.50%-30.78M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 69.53%-48.83M | 82.48%-5.04M | 92.76%-2.63M | 78.55%-13.82M | 11.18%-27.34M | -16.59%-160.28M | -4.87%-28.79M | -80.06%-36.27M | -1.56%-64.43M | -16.50%-30.78M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 69.53%-48.83M | 82.48%-5.04M | 92.76%-2.63M | 78.55%-13.82M | 11.18%-27.34M | -16.59%-160.28M | -4.87%-28.79M | -80.06%-36.27M | -1.56%-64.43M | -16.50%-30.78M |
| Basic earnings per share | 74.50%-0.51 | 82.76%-0.05 | 92.68%-0.03 | 83.13%-0.14 | 37.50%-0.3 | 12.66%-2 | 34.09%-0.29 | -24.24%-0.41 | 22.43%-0.83 | -6.67%-0.48 |
| Diluted earnings per share | 74.50%-0.51 | 82.76%-0.05 | 92.68%-0.03 | 83.13%-0.14 | 37.50%-0.3 | 12.66%-2 | 34.09%-0.29 | -24.24%-0.41 | 22.43%-0.83 | -6.67%-0.48 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.